Zhejiang Medicine Statistics

Total Valuation

SHA:600216 has a market cap or net worth of CNY 13.14 billion. The enterprise value is 11.62 billion.

Market Cap	13.14B
Enterprise Value	11.62B

Important Dates

The last earnings date was Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	Jul 10, 2024

Share Statistics

SHA:600216 has 961.64 million shares outstanding. The number of shares has decreased by -2.03% in one year.

Current Share Class	n/a
Shares Outstanding	961.64M
Shares Change (YoY)	-2.03%
Shares Change (QoQ)	+1.22%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	5.82%
Float	582.82M

Valuation Ratios

The trailing PE ratio is 8.87 and the forward PE ratio is 10.16.

PE Ratio	8.87
Forward PE	10.16
PS Ratio	1.40
PB Ratio	1.17
P/TBV Ratio	1.26
P/FCF Ratio	15.52
P/OCF Ratio	8.73
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.51, with an EV/FCF ratio of 13.73.

EV / Earnings	7.96
EV / Sales	1.24
EV / EBITDA	4.51
EV / EBIT	6.40
EV / FCF	13.73

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.07.

Current Ratio	2.85
Quick Ratio	1.91
Debt / Equity	0.07
Debt / EBITDA	0.31
Debt / FCF	0.94
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 12.43% and return on invested capital (ROIC) is 9.87%.

Return on Equity (ROE)	12.43%
Return on Assets (ROA)	8.43%
Return on Invested Capital (ROIC)	9.87%
Return on Capital Employed (ROCE)	15.63%
Revenue Per Employee	1.51M
Profits Per Employee	234,454
Employee Count	6,227
Asset Turnover	0.70
Inventory Turnover	2.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +49.40% in the last 52 weeks. The beta is 0.57, so SHA:600216's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	+49.40%
50-Day Moving Average	14.14
200-Day Moving Average	14.96
Relative Strength Index (RSI)	53.46
Average Volume (20 Days)	22,093,623

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:600216 had revenue of CNY 9.38 billion and earned 1.46 billion in profits. Earnings per share was 1.54.

Revenue	9.38B
Gross Profit	4.21B
Operating Income	1.81B
Pretax Income	1.57B
Net Income	1.46B
EBITDA	2.55B
EBIT	1.81B
Earnings Per Share (EPS)	1.54

Full Income Statement

Balance Sheet

The company has 2.51 billion in cash and 796.70 million in debt, giving a net cash position of 1.71 billion or 1.78 per share.

Cash & Cash Equivalents	2.51B
Total Debt	796.70M
Net Cash	1.71B
Net Cash Per Share	1.78
Equity (Book Value)	11.27B
Book Value Per Share	11.63
Working Capital	4.43B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.51 billion and capital expenditures -658.78 million, giving a free cash flow of 846.32 million.

Operating Cash Flow	1.51B
Capital Expenditures	-658.78M
Free Cash Flow	846.32M
FCF Per Share	0.88

Full Cash Flow Statement

Margins

Gross margin is 44.84%, with operating and profit margins of 19.35% and 15.56%.

Gross Margin	44.84%
Operating Margin	19.35%
Pretax Margin	16.68%
Profit Margin	15.56%
EBITDA Margin	27.21%
EBIT Margin	19.35%
FCF Margin	9.02%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 1.10%.

Dividend Per Share	0.15
Dividend Yield	1.10%
Dividend Growth (YoY)	-11.76%
Years of Dividend Growth	n/a
Payout Ratio	11.60%
Buyback Yield	2.03%
Shareholder Yield	3.13%
Earnings Yield	11.11%
FCF Yield	6.44%

Dividend Details

Stock Splits

The last stock split was on October 9, 2013. It was a forward split with a ratio of 1.8.

Last Split Date	Oct 9, 2013
Split Type	Forward
Split Ratio	1.8

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a